COVID-19

Pharma Courses 
PAGE Admission

  • U.S. Food and Drug Administration is providing an update on the agency’s efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic. In response to scammers on the internet selling unproven medical products, the FDA has taken – and continues to take – a number of steps to find and stop those selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19.

  • Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India’s drug regulator DCGI in late April. Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India. Favipiravir is a generic version of Avigan® of Fujifilm Toyama Chemical Co. Ltd., Japan, a subsidiary of Fujifilm Corporation. Clinical trials have commenced and over 10 leading government & private hospitals in India are being enrolled for the study. Glenmark estimates study completion by July/August 2020.

  • 11 May 2020
    Pharmacist Hero Vol 7

    PharmaTutor facilitating these Pharmacy warriors who are contributing against fight of COVID-19. This is Volume 7. We shall keep posting list of more Pharmacist Heroes.

    Any pharmacist from industry, academics, researcher or community pharmacist who contributing actively for fight aganist COVID-19 can send their details.

     

  • To urgently develop safe and effective Biomedical solutions against SARS CoV-2, Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) had invited applications for COVID-19 Research Consortium. In addition, BIRAC has also created a provision to fund COVID-19 solutions that are ready for immediate deployment under a ‘Fast Track Review Process’.

  • 9 May 2020
    A tale of Novel Coronavirus

    Feb 24 2020: “The Coronavirus is very much under control in the USA.”

    Mar 29 2020: “If we have between 100,000 and 200,000 (deaths) we’ve all together done a very good job”

    In a month, statements from President Trump took a U-turn suggesting his coronavirus rhetoric have not worked in favor of the United States. Also, statements of assurance due to Covid-19 were in stark contrast to projected infections and deaths being laid out by CDC (Centers for Disease Control and prevention) on their website during February. Being the most powerful nation in terms of military and economic strength is of little use if the nation is fighting a highly contagious and pathogenic virus. South Korea and the United States reported their first case of confirmed Covid-19 infection at a similar time, yet South Korea has done exceedingly well to contain the spread whereas the United States has the highest number of deaths in the entire world. The death rate due to Covid-19 seems to be very high in the United States compared to Asian countries like South Korea, Taiwan, India, Singapore etc. suggesting that Americans have lower immunity to these types of viruses, and therefore It was imperative for the United states to treat the matter with utmost gravity.

  • A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more effective at reducing the duration of viral shedding than lopinavir-ritonavir alone in patients with mild to moderate illness, according to the first randomised trial of this triple combination therapy involving 127 adults (aged 18 and older) from six public hospitals in Hong Kong.

  • The PM took a detailed review of the current status of India’s efforts in vaccine development, drug discovery, diagnosis and testing. Indian vaccine companies are well known for their quality, manufacturing capacity and global presence. Today in addition, they have come across as innovators in early stage vaccine development research. Similarly, Indian academia and start-ups have also pioneered in this area. Over 30 Indian vaccines are in different stages of corona vaccine development, with a few going on to the trial stages.

  • Health Minister Sh. Harsh Vardhan and Minister of State for AYUSH  Sh. Shripad Yesso Naik jointly launched clinical research studies on Ayurveda interventions as an add-on to standard care to COVID 19 situation and Ayush Sanjivani application today at New Delhi. AYUSH Minister was participating in the programme through Video Conferencing from Goa.

Subscribe to COVID-19